Democratic Senators Call for Transparency: DEA Urged to Disclose Actions on HHS Recommendations for Cannabis Rescheduling

On January 29, a group of 12 Democratic senators, led by Elizabeth Warren, penned a letter to the DEA and Attorney General Merrick Garland. They raised six key questions regarding the ongoing review of cannabis rescheduling, including the status, evidence utilized, and anticipated timeline. The senators urged the DEA to consider 'descheduling' cannabis altogether, citing its adverse effects on communities and misalignment with state laws and public opinion.

Despite setting a deadline of February 12 for a response, the DEA has yet to reply, as confirmed by the recent report from Cannabis Business Times. This letter adds to the chorus of calls across political lines for increased transparency and expedited decision-making on rescheduling.

Earlier this week, Congressman Earl Blumenauer, a co-chair of the Congressional Cannabis Caucus, echoed these sentiments, urging the DEA to outline a clear timeline for rescheduling. Congressman Steve Cohen also pressed the agency to act swiftly on recommendations from the HHS.

These developments coincide with speculation surrounding a potential imminent announcement regarding rescheduling, fueled by recent statements from prominent figures. However, government officials have denied any impending changes.